Patient Empowerment Program: A Rare Disease Podcast
Science Podcasts
Join the nano-rare disease community! Interviews features leading physicians, scientists, biotech experts, and patient advocates. Lessons teach core concepts about drugs. Our host Dr. Crooke has led the creation of antisense technology and his foundation, n-Lorem, is using this powerful technology to discover, develop, and provide personalized experimental antisense oligonucleotide medicines to nano-rare patients for free, for life. n-Lorem is a non-profit organization established to apply the efficiency, versatility and specificity of antisense technology to charitably provide experimental antisense oligonucleotide (ASO) medicines to treat patients (less than 30 patients) that are the result of a single genetic defect unique to only one or very few individuals. The advantage of experimental ASO medicines is that they can be developed rapidly, inexpensively and are highly specific. n-Lorem was founded by Dr. Stan Crooke, who founded IONIS Pharmaceuticals in 1989 and, through his vision and leadership, established the company as the leader in RNA-targeted therapeutics. This podcast is produced by n-Lorem Foundation and hosted by Dr. Stanley T. Crooke, who is our Founder, CEO and Chairman. Our videographer is Jon Magnuson. Our producers are Kira Dineen, Jon Magnuson, Kim Butler, and Amy Williford. To learn more about n-Lorem, visit nlorem.org. Contact us at podcast@nlorem.org.
Location:
United States
Genres:
Science Podcasts
Description:
Join the nano-rare disease community! Interviews features leading physicians, scientists, biotech experts, and patient advocates. Lessons teach core concepts about drugs. Our host Dr. Crooke has led the creation of antisense technology and his foundation, n-Lorem, is using this powerful technology to discover, develop, and provide personalized experimental antisense oligonucleotide medicines to nano-rare patients for free, for life. n-Lorem is a non-profit organization established to apply the efficiency, versatility and specificity of antisense technology to charitably provide experimental antisense oligonucleotide (ASO) medicines to treat patients (less than 30 patients) that are the result of a single genetic defect unique to only one or very few individuals. The advantage of experimental ASO medicines is that they can be developed rapidly, inexpensively and are highly specific. n-Lorem was founded by Dr. Stan Crooke, who founded IONIS Pharmaceuticals in 1989 and, through his vision and leadership, established the company as the leader in RNA-targeted therapeutics. This podcast is produced by n-Lorem Foundation and hosted by Dr. Stanley T. Crooke, who is our Founder, CEO and Chairman. Our videographer is Jon Magnuson. Our producers are Kira Dineen, Jon Magnuson, Kim Butler, and Amy Williford. To learn more about n-Lorem, visit nlorem.org. Contact us at podcast@nlorem.org.
Twitter:
@n_lorem
Language:
English
Contact:
7605527113
Website:
https://www.nlorem.org
Email:
podcast@nlorem.org
Mostyn's Story: Mother's Day Special with Zoe Hummel
Duration:00:50:06
Physicians and Institutions Transform the Lives of Nano-rare Patients with Olivia Kim-McManus, M.D.
Duration:00:48:53
Advanced Genetics Part 2
Duration:00:25:52
Advanced Genetics Part 1
Duration:00:30:13
Sharing Hope Through Storytelling & Connection with Shanna Tolbert
Duration:00:43:08
Our Mission is Personal with Sarah Glass
Duration:00:40:54
Q&A #2 with Patient Families
Duration:00:45:45
Everybody Lives with Dan Doctoroff
Duration:00:48:37
Best of the 2023 Nano-rare Patient Colloquium
Duration:00:39:02
How to Think About "Risk" Part 2
Duration:00:35:28
How to Think About "Risk" Part 1
Duration:00:42:35
Inheriting Huntington's Disease and Aspiring to Prolong Lives with Jeff Carroll
Duration:00:38:43
Living a Longer, Healthier, and More Fun Life with Chip Wilson
Duration:01:00:16
Living a Longer, Healthier, and More Fun Life with Chip Wilson
Duration:01:00:16
Autopilot: The Autonomic Nervous System
Duration:00:22:04
Better Health, Brighter Future for Rare with Dan Curran
Duration:00:29:52
Sneak Peek of the 2023 Nano-rare Patient Colloquium
Duration:00:36:04
Liver: Diseases
Duration:00:14:40
Liver: The Master Chemist
Duration:00:20:23
Liver: Metabolic Magic
Duration:00:30:00